Clinical and Laboratory Predictors for Plaque Erosion in Patients With Acute Coronary Syndromes
Background: Plaque erosion is responsible for 25% to 40% of patients with acute coronary syndromes (ACS). Recent studies suggest that anti-thrombotic therapy without stenting may be an option for this subset of patients. Currently, however, an invasive procedure is required to make a diagnosis of pl...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
Ovid Technologies (Wolters Kluwer Health)
2021
|
Online Access: | https://hdl.handle.net/1721.1/128946 |